Abstract:Candida spp. are commensal organisms of the skin, mucous membranes, gastrointestinal tract, blood, and vagina of animals and humans. In recent decades, the incidence of human fungal infections has increased, with Candida spp. (mainly C. albicans) infections being the most frequent, and the treatment of fungal infections is still a clinical challenge. Colonization of the human gastrointestinal tract by Candida spp. is significant because infections (e.g., candidemia and vulvovaginal candidiasis) frequently arise from commensal microorganisms. The aim of this study was to test in vitro the antifungal activity and the eventual synergistic effect of five pure components of essential oils: cinnamaldehyde, α-pinene, limonene, eucalyptol, and eugenol. These compounds were tested on 18 Candida strains (15 C. albicans, 2 C. glabrata, and 1 C. lusitaniae) derived from a culture collection of vaginal clinical strains. Methods: Fungistatic activity was evaluated using the disk diffusion method. For fungicidal activity, microdilution and time–kill curve protocols were set up. The checkerboard method was chosen to evaluate a possible synergistic effect of these compounds when mixed. Results: Cinnamaldehyde and eugenol gave the best results, inhibiting all the Candida strains and showing a highly additive effect (FICI 0.625). The cinnamaldehyde inhibition zone (IZ), MIC, and MFC means were 69 mm, 50.05 mg/L, and 109.26 mg/L respectively. Cinnamaldehyde led to the total loss of viable Candida cells within 4 h. Eugenol IZ, MIC, and MFC means were 35.2 mm, 455.42 mg/L, and 690.09 mg/L, respectively. Eugenol led to the total loss of viable fungal cells within 1 h. Treatment with α-pinene inhibited 88.9% of Candida strains, with an IZ mean of 21.2 mm, a MIC mean of 195.41 mg/L, and a MFC mean of 251.27 mg/L; this compound led to the total loss of viable fungal cells only after 24 h. Limonene inhibited only 33.3% of the tested strains and eucalyptol did not produce an inhibition halo, so these compounds were not tested further. Conclusions: These characteristics, together with the well-known safety of cinnamaldehyde and eugenol for human use, make these two natural compounds the perfect candidates for the treatment of candidiasis. This was a pilot study, the purpose of which was to evaluate the best composition of a mixture to be used against intestinal and vulvovaginal candidiasis; in vivo studies are needed to confirm these very encouraging results.

In vitro inhibitory activities of magnolol against Candida spp.

Magnolol as a potent antifungal agent inhibits <i>Candida albicans</i> virulence factors <i>via</i> the PKC and Cek1 MAPK signaling pathways

Magnolol as a potent antifungal agent inhibits Candida albicans virulence factors via the PKC and Cek1 MAPK signaling pathways

Effects of Magnolol and Honokiol on Adhesion, Yeast-Hyphal Transition, and Formation of Biofilm by Candida Albicans.

Mechanistic insights of magnolol antimicrobial activity against Mycoplasma using untargeted metabolomic analyses

Antimicrobial Activity of Magnolol Against Bacillus Cereus and Its Application As Food Preservative

In Vitro Antifungal Effects of Berberine Against Candida Spp. in Planktonic and Biofilm Conditions

Design, Synthesis, and Structure-Activity Relationship Studies of Magnolol Derivatives As Antifungal Agents

Antifungal Activity of Minocycline and Azoles Against Fluconazole-Resistant Candida Species

Transcriptomic Insights into the Antifungal Effects of Magnolol on the Growth and Mycotoxin Production of Alternaria alternata

In Vitro Activity of Eugenol Against Candida Albicans Biofilms.

Antifungal activities of Equol against Candida albicans in vitro and in vivo

In Vitro Activity of Verapamil Alone and in Combination with Fluconazole or Tunicamycin Against Candida Albicans Biofilms.

Magnolol Inhibits Colletotrichum. Gloeosporioides Via Disruption of Plasma Membrane and Induction of Reactive Oxygen Species Accumulation

[Sensitivity of yeasts of the genus Candida to new antifungal agents]

The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans

Transcriptional And Functional Analysis Of The Effects Of Magnolol: Inhibition Of Autolysis And Biofilms In Staphylococcus Aureus

Antifungal Activity of Natural Compounds vs. Candida spp.: A Mixture of Cinnamaldehyde and Eugenol Shows Promising In Vitro Results

Potent and Selective Inhibition of Magnolol on Catalytic Activities of Ugt1a7 and 1A9

Antifungal activity of Cinnamaldehyde derivatives against fluconazole-resistant Candida albicans

Study on in Vitro Antifungal Activity of Thymol